Researchers today are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes, which is associated with a range of eye diseases such as diabetic retinopathy.. Early results suggest participant diversity and novel measures will enable new, artificial intelligence-driven insights.